Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-24-000014

Chief Financial Officer gave up 1,301 shares (to pay taxes)

  • Chief Financial Officer acquired 36,700 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Adams Kendra · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-02-13 Shares withheld for taxes : show line 1 in the form −1,301 $6.53 $8,496 45,339 D
2024-02-14 Grant or award : show line 2 in the form +36,700 82,039 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-02-14 Grant or award : show line 3 in the form Stock Option (Right to Buy) +165,300 165,300 D
Loading xslF345X05/wk-form4_1708034519.xml…